NewslettersHuman Immunology NewsImmune Regulation NewsTraverse Biotech Awarded Phase I SBIR Grant by the National Institute of Allergy and Infectious Diseases for Development of Innate Immune StimulatorBy lbeveridge - May 7, 2024093Traverse Biotech, Inc. has been awarded a Phase I Small Business Innovation Research grant from the National Institute of Allergy and Infectious Diseases, part of the NIH.[Traverse Biotech, Inc. (PR Newswire)]Press Release